Since the discovery of the SERPINB3 (a.k.a. squamous cell carcinoma antigen (SCCA)) in 1977, numerous clinical reports show that elevated circulating levels of this protein are a poor prognostic factor for patients with advanced squamous cell carcinomas and other epithelial malignancies111,112. This evidence concerns the gene SERPINB3 and squamous cell carcinoma.